Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID ...

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...

Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine ...

to develop bird flu vaccines over increasing fears of widespread transmission of the infection. Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, ...